Afuco™ Anti-RAAG12 ADCC Therapeutic Antibody (RAV12), ADCC Enhanced
Anti-RAAG12 ADCC Enhanced Antibody (RAV12) is an ADCC enhanced antibody produced by our Afuco™ platform. RAV12 binds to RAAG12-expressing gastrointestinal adenocarcinomas, and has antitumor activity toward gastrointestinal tumor xenografts.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-747CL |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | RAAG12 |
| Type | ADCC enhanced antibody |
| Applications | IHC, Cyt, Inhib, FuncS |
| Storage | ≤1 year at -20°C. |